Mirjana Rajer
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment.
Journal: Journal of clinical medicine
Published: January 15, 2022
Budget projections and clinical impact of an immuno-oncology class of treatments: Experience in four EU markets.
Journal: Journal of cancer policy
Published: September 30, 2020
Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Journal: Radiology and oncology
Published: January 09, 2020
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.
Journal: Cancer biology & therapy
Published: June 05, 2016
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations.
Journal: Radiology and oncology
Published: August 25, 2014
Pollution in the working place and social status: co-factors in lung cancer carcinogenesis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 30, 2014
The role of PET-CT in radiotherapy planning of solid tumours.
Journal: Radiology and oncology
Published: April 01, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026